Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated falciparum malaria in Thailand
ACTRN12611000407998Phase 4Not yet recruiting
- Sponsor
- Bureau of Vector Borne Diseases
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lumefantrine in Malaria, sponsored by Bureau of Vector Borne Diseases. Primary endpoint: WHO-classified treatment outcome. Planned start May 2011; status: not yet recruiting.
02
Drugs
lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12611000407998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000407998.